Ambroxol is a mucolytic drug that helps to dilute sputum and facilitate the process of its removal from the lungs.
Release form and composition
The following dosage forms of Ambroxol are made:
- Tablets of 30 mg ordinary, effervescent or prolonged action, in a package of 50 pieces;
- Ampoules 15 ml;
- Syrup with a content of 15 mg or 30 mg of the drug in 5 ml, in vials of 100 ml;
- Solution for inhalation with a content of 15 mg of the drug in 2 ml, in vials of 100 ml.
The active ingredient of Ambroxol is Ambroxol Hydrochloride.
Indications for use of Ambroxol
According to the instructions, Ambroxol is shown when:
- Chronic and acute diseases of the respiratory tract, accompanied by the release of sputum (bronchial asthma, chronic bronchitis with broncho-obstructive syndrome, bronchiectasis);
- Respiratory Distress Syndrome in Premature and Newborn Babies.
According to the instructions, Ambroxol should not be taken in the presence of hypersensitivity to the active or auxiliary components of the drug.
Ambroxol tablets are contraindicated in children under 6 years.
In the use of Ambroxol, caution should be exercised with gastric and duodenal ulcers, as well as with renal or hepatic insufficiency.
Ambroxol is contraindicated in the first trimester of pregnancy. Prescribe medication in the second and third trimesters should be based on the potential benefits to the mother and the possible danger to the fetus.
If there is a need to use the drug during lactation, you should stop breastfeeding for the duration of treatment.
Administration and dosage of Ambroxol
Ambroxol tablets and syrup are intended for internal use. Ambroxol syrup is prescribed, as a rule, in a dosage of 30 mg at a time (for children over 12 years old and adults). For children under 12 years old, syrup is prescribed at a dose of 15 mg at one time. Syrup is taken three times a day.
Ambroxol tablets are taken during a meal, washed down with a small amount of liquid. Children over 12 years old and adults take the medicine three times a day according to the following scheme: the first 2-3 days, 30 mg per day, after which you can switch to 15 mg per day or continue to take 30 mg twice a day.
Ambroxol tablets are prescribed for children from 6 to 12 years old at a dosage of 15 mg divided into two or three doses.
According to the instructions, Ambroxol in the form of a solution is administered orally three times a day according to the following scheme:
- The first 2-3 days, 4 ml;
- Subsequent days of treatment - 2 ml per day.
Children aged 2-5 take Ambroxol as a solution, 1 ml three times a day, children under two years old - 1 ml twice a day.
Ambroxol for inhalation is prescribed to children 5–12 years old, 1 inhalation per day, after 12 years, and for adult patients, 2 inhalations per day.
Do not use Ambroxol for more than five days without a doctor's supervision.
After use, the drug begins to act after half an hour and retains a therapeutic effect for 9-10 hours.
Side Effects of Ambroxol
Ambroxol may cause the following side effects:
- Allergies: skin rash, urticaria, allergic contact dermatitis, angioedema, anaphylactic shock;
- The digestive system: dry mouth, diarrhea, constipation, nausea, vomiting, gastralgia;
- Respiratory system: rhinorrhea, dry mucous membranes of the respiratory tract;
- Other side effects: rash, dysuria, headache, weakness.
It is not recommended to combine Ambroxol with antitussive drugs that impede the excretion of sputum.
In the combination of Ambroxol with cefuroxime, erythromycin, doxycycline, amoxicillin, their penetration into the bronchial secretion is increased.
In patients with asthma before inhalation, it is recommended to use bronchodilators in order to avoid specific irritation of the respiratory tract and their spasm.
Ambroxol syrup can be prescribed to patients with diabetes.
Ambroxol analogs are the following drugs:
Terms and conditions of storage
The drug should be stored in a dry dark place out of the reach of children. The shelf life is 3 years from the date of manufacture.